Highlands Cancer Center


Real People, Real Stories

Zip Wells of Inez, KY
Small Cell Lung Cancer

Zip is a retired construction worker who was diagnosed with...Read Story

Mary Preston of Inez, KY
Lung Cancer

Highlands Cancer Center has helped with the support...Read Story

Henry McKenzie of Prestonsburg, KY
Colon Cancer

Henry was losing weight without any explanation for about a year...Read Story

Roger Owens of Oil Springs, KY
Tongue Cancer

"My name is Roger Owens and I am Cancer Free!!!...Read Story

Marietta Music of Paintsville, KY
Breast Cancer

"My story is about knowing your own body… Read Story

Marcus Russell of Salyersville, KY

“In February of 2010 I was diagnosed with...Read Story


Radioimmunotherapy is a new weapon in the fight against cancer. Zevalin is the first Radioimmunotherapy treatment to be approved by the Food and Drug Administration in the treatment of certain types of non-Hodgkins lymphoma.

Zevalin is different in many ways from conventional chemotherapy or external beam radiation therapy.

Radioimmunotherapy is a treatment that uses a radiation source, such as a radioisotope, with a component of the immune system, such as an antibody. Zevalin combines the cell targeting ability of a monoclonal antibody with the additional cell killing ability of a radioactive material called Yttrium-90.

The monoclonal antibody recognizes and attaches to a particular part of a B-Cell, called the CD20 antigen. This process allows Zevalin to specifically target B-cells, therefore destroying malignant NHL B-Cells.

Treatment can be completed within a week on an out-patient basis. This regime is generally well tolerated by the patients and can be given safely and effectively in a community cancer center.